Table 2.
Baseline characteristics CAD patients stratified by T2DM
| Characteristics | Overall | without T2DM | T2DM | P value |
|---|---|---|---|---|
| 5,960 | 4,072 | 1,888 | ||
| Age, years | 62.8 (10.4) | 62.6 (10.6) | 63.2 (9.9) | 0.027 |
| Female | 1435 (24.1) | 908 (22.3) | 527 (27.9) | < 0.001 |
| Smoking history | 1379 (23.8) | 1007 (25.4) | 372 (20.3) | < 0.001 |
| Acute myocardial infarction | 958 (16.1) | 640 (15.7) | 318 (16.8) | 0.288 |
| Hypertension | 3639 (61.1) | 2327 (57.1) | 1312 (69.5) | < 0.001 |
| Type 2 diabetes mellitus | 1888 (31.7) | 0 (0.0) | 1888 (100.0) | < 0.001 |
| Congestive heart failure | 768 (12.9) | 478 (11.7) | 290 (15.4) | < 0.001 |
| Chronic kidney disease | 971 (16.3) | 540 (13.3) | 431 (22.8) | < 0.001 |
| Atrial fibrillation | 256 (4.3) | 168 (4.1) | 88 (4.7) | 0.379 |
| Stroke | 460 (7.7) | 277 (6.8) | 183 (9.7) | < 0.001 |
| Hyperlipemia | 4021 (67.5) | 2620 (64.3) | 1401 (74.2) | < 0.001 |
| Anemia | 1941 (33.5) | 1197 (30.2) | 744 (40.5) | < 0.001 |
| PCI | 4397 (73.8) | 2918 (71.7) | 1479 (78.3) | < 0.001 |
| uACR, mg/g | 14.3 (48.5) | 8.7 (33.1) | 26.5 (69.7) | < 0.001 |
| eGFR, mL/min/1.73m2 | 92.7 (46.8) | 93.4 (44.6) | 91.4 (51.2) | 0.126 |
| Hemoglobin, g/L | 133.2 (17.2) | 134.7 (16.3) | 129.8 (18.8) | < 0.001 |
| LDLC, mmol/L | 2.8 (0.9) | 2.9 (0.9) | 2.8 (0.9) | < 0.001 |
| HDLC, mmol/L | 1.0 (0.2) | 1.0 (0.2) | 0.9 (0.2) | < 0.001 |
| LVEF, n(%) | 58.8 (11.9) | 59.5 (11.5) | 57.3 (12.3) | < 0.001 |
| HbA1c, n(%) | 6.5 (1.4) | 5.8 (0.6) | 7.8 (1.6) | < 0.001 |
| ACEI/ARB | 3961 (66.9) | 2701 (66.7) | 1260 (67.3) | 0.623 |
| β-blocker | 4937 (83.4) | 3338 (82.4) | 1599 (85.5) | 0.004 |
| Statins | 5030 (84.9) | 3434 (84.7) | 1596 (85.3) | 0.607 |
| Spironolactone | 682 (11.5) | 409 (10.1) | 273 (14.6) | < 0.001 |
| Dual antiplatelet therapy | 4256 (71.9) | 2869 (70.8) | 1387 (74.1) | 0.009 |
Values are mean ± SD, n (%), or median (IQR).
PCI: percutaneous coronary intervention; uACR: urine albumin creatinine ratio; eGFR: estimated glomerular filtration rate; LDLC: low density lipoprotein cholesterol; HDLC: high density lipoprotein cholesterol; HbAlc: glycosylated hemoglobin; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers